Comparing injecting and sexual risk behaviors of long-term injectors with new injectors: A meta-analysis

References

• Aragonés-López C, Pérez-Ávila J, Smith Fawzi MC, Castro A. Quality of life of people with HIV/AIDS receiving antiretroviral therapy in Cuba: A cross-sectional study of the national population. Am J Public Health 2012;102:884–92. doi:10.2105/AJPH.2011.300450.
   PubMed Web of Science ®Google Scholar
• Cook C, Murphy F, Phelan M, Sander G, Stone K. The case for a harm reduction decade: progress, potential and paradigm shifts. Harm Reduction International, London. 2016.
   Google Scholar
• Razzaghi E, Nassirimanesh B, Afshar P, Ohiri K, Claeson M, Power R. HIV/AIDS harm reduction in Iran. Lancet 2006;368:434–5. doi:10.1016/S0140-6736(06)69132-0.
   PubMed Web of Science ®Google Scholar
• Bazrafshan MR, Noroozi M, Ghisvand H, et al. Comparing injecting risk behaviors of long-term injectors with new injectors in Tehran, Iran. Subst Use Misuse 2019;54(2):185–190.
   PubMed Web of Science ®Google Scholar
• Bryant J, Treloar C. Initiators: an examination of young injecting drug users who initiate others to injecting. AIDS Behav 2008;12:885–90. Nov doi:10.1007/s10461-007-9347-z.
   PubMed Web of Science ®Google Scholar
• Fuller CM, Vlahov D, Arria AM, Ompad DC, Garfein R, Strathdee SA. Factors associated with adolescent initiation of injection drug use. Public Health Rep 2001;116:136–45. doi:10.1093/phr/116.S1.136.
   PubMed Web of Science ®Google Scholar
• Jorjoran Shushtari Z, Noroozi A, Mirzazadeh A, et al. Comparing characteristics of early-onset injection drug users to those with late-onset injection in Kermanshah, Iran. Subst Use Misuse 2017;52:754–9. doi:10.1080/10826084.2016.1263666.
   PubMed Web of Science ®Google Scholar
• Chitwood DD, Comerford M, Kitner KR, Palacios W, Sanchez J. A comparison of HIV risk behaviors between new and long-term injection drug users. Subst Use Misuse 2001;36:91–111.
   PubMed Web of Science ®Google Scholar
• Fuller CM, Vlahov D, Ompad DC, Shah N, Arria A, Strathdee SA. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend. 2002;66:189–98. doi:10.1016/S0376-8716(01)00200-9.
   PubMed Web of Science ®Google Scholar
• Des Jarlais DC, Mesquita F, Bueno R, et al. New injectors and HIV-1 risk. Drug injecting and HIV infection. London: Routledge, 2003:94–108.
   Google Scholar
• Des Jarlais DC, Friedman SR, Perlis T, Chapman TF, Sotheran JL, Paone D, Monterroso E, Neaigus A. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:67–72.
   PubMedGoogle Scholar
• Neaigus A, Friedman SR, Jose B, Goldstein MF, Curtis R, Ildefonso G, Des Jarlais DC. High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:499–509.
   PubMedGoogle Scholar
• Friendman S, Friendman P, Telles P, Bastos F, Bueno R, Mesquita F. New injectors and HIV-1 risk. Drug injecting and HIV infection. London: Routledge. 1998; 76–90.
   Google Scholar
• Noroozi M, Farhadi MH, Armoon B, et al. Factors associated with time between using a drug and injection initiation among people who inject drugs in Kermanshah, Iran. Int J Adolesc Med Health. 2018.
   Google Scholar
• Friedman SR, Curtis R, Neaigus A, Jose B, Des Jarlais DC. Social networks, drug injectors' lives, and HIV/AIDS. XX, 277. Springer Science & Business Media.
   Google Scholar
• Friedman S, Des Jarlais D, Jose B, Neaigus A, Goldstein M. Seroprevalence, seroconversion, and the history of the HIV epidemic among drug injectors. HIV epidemiology. New York, NY: Raven, 1994:137–50.
   Google Scholar
• Bautista CT, Todd CS, Abed AMS, Botros BA, Strathdee SA, Earhart KC, Safi N, Scott PT. Effects of duration of injection drug use and age at first injection on HCV among IDU in Kabul, Afghanistan. J Public Health (Oxf) 2010;32:336–41. doi:10.1093/pubmed/fdq020.
   PubMed Web of Science ®Google Scholar
• Montain J, Ti L, Hayashi K, Nguyen P, Wood E, Kerr T. Impact of length of injecting career on HIV incidence among people who inject drugs. Addict Behav 2016;58:90–4. doi:10.1016/j.addbeh.2016.02.020.
   PubMed Web of Science ®Google Scholar
• Nelson KE, Eiumtrakul S, Celentano DD, Beyrer C, Galai N, Kawichai S, Khamboonruang C. HIV infection in young men in northern Thailand, 1991-1998: increasing role of injection drug use. J Acquir Immune Defic Syndr2002;29:62–8. doi:10.1097/00126334-200201010-00009.
   PubMed Web of Science ®Google Scholar
• Thorpe LE, Ouellet LJ, Levy JR, Williams IT, Monterroso ER. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997–1999. J Infect Dis 2000;182:1588–94. doi:10.1086/317607.
   PubMed Web of Science ®Google Scholar
• Chitwood DD, Sanchez J, Comerford M, Page JB, McBride DC, Kitner KR. First injection and current risk factors for HIV among new and long-term injection drug users. AIDS Care 2000;12:313–20. doi:10.1080/09540120050042972.
   PubMed Web of Science ®Google Scholar
• Hacker MA, Friedman SR, Telles PR, Teixeira SL, Bongertz V, Morgado MG, Bastos FI. The role of “long-term” and “new” injectors in a declining HIV/AIDS epidemic in Rio de Janeiro, Brazil. Subst Use Misuse 2005;40:99–123.
   PubMed Web of Science ®Google Scholar
• Rezaei F, Noroozi A, Armoon B, Farhoudian A, Massah O, Sharifi H, Ahounbar E, Khodadost M, Mohammadi F, Barkhordar N, et al. Social determinants and hepatitis C among people who inject drugs in Kermanshah, Iran: Socioeconomic status, homelessness, and sufficient syringe coverage. J Subst Use 2017;22:474–8. doi:10.1080/14659891.2016.1245793.
   Web of Science ®Google Scholar
• Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation. BMJ. 2015;349:g7647. doi:10.1136/bmj.g7647.
   PubMed Web of Science ®Google Scholar
• Ghaffari M, Rakhshanderou S, Ramezankhani A, Buunk-Werkhoven Y, Noroozi M, Armoon B. Are educating and promoting interventions effective in oral health? A systematic review. Int J Dent Hygiene 2018;16:48–58. doi:10.1111/idh.12305.
   PubMed Web of Science ®Google Scholar
• Ghaffari M, Armoon B, Rakhshanderou S, Mehrabi Y, Soori H, Simsekoghlu O, Harooni J. Determinants of seat belt use behaviour: a protocol for a systematic review. BMJ Open. 2018;8:e020348. doi:10.1136/bmjopen-2017-020348.
   PubMed Web of Science ®Google Scholar
• Ghaffari M, Rakhshanderou S, Ramezankhani A, Noroozi M, Armoon B. Oral health education and promotion programmes: Meta-analysis of 17-year intervention. Int J Dent Hygiene 2018;16:59–67. doi:10.1111/idh.12304.
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603–5. doi:10.1007/s10654-010-9491-z.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Green S (Editors). Cochrane handbook for systematic reviews of interventions. Chichester (UK): John Wiley & Sons, 2011.
   Google Scholar
• Thabet M, Eman E, Abood SA, Morsy SR. The effect of problem-based learning on nursing students' decision making skills and styles. J Nurs Educ Pract 2017;7:108. doi:10.5430/jnep.v7n6p108.
   Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088–101. doi:10.2307/2533446.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–34. doi:10.1136/bmj.315.7109.629.
   PubMed Web of Science ®Google Scholar
• Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D. Correlates of HIV infection among young adult short-term injection drug users. AIDS (London, England). 2000;14:717–26. doi:10.1097/00002030-200004140-00011.
   PubMed Web of Science ®Google Scholar
• Novelli LA, Sherman SG, Havens JR, Strathdee SA, Sapun M. Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users. Drug Alcohol Depend 2005;77:303–9. doi:10.1016/j.drugalcdep.2004.08.021.
   PubMed Web of Science ®Google Scholar
• Uusküla A, Kals M, Rajaleid K, et al. High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs. J Public Health (Oxf) 2008;30:119–25. doi:10.1093/pubmed/fdn014.
   PubMed Web of Science ®Google Scholar
• Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18: S11–S9. doi:10.1097/00042560-199802001-00004.
   PubMed Web of Science ®Google Scholar
• Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996;86:655–61. doi:10.2105/ajph.86.5.655.
   PubMed Web of Science ®Google Scholar
• Arreola S, Bluthenthal RN, Wenger L, Chu D, Thing J, Kral AH. Characteristics of people who initiate injection drug use later in life. Drug Alcohol Depend 2014;138:244–50. doi:10.1016/j.drugalcdep.2014.02.026.
   PubMed Web of Science ®Google Scholar
• Crofts N, Louie R, Rosenthal D, Jolley D. The first hit: circumstances surrounding initiation into injecting. Addiction (Abingdon, England) 1996;91:1187–96. doi:10.1046/j.1360-0443.1996.918118710.x.
   PubMed Web of Science ®Google Scholar
• Abelson J, Treloar C, Crawford J, Kippax S, van Beek I, Howard J. Some characteristics of early-onset injection drug users prior to and at the time of their first injection. Addiction (Abingdon, England) 2006;101:548–55. doi:10.1111/j.1360-0443.2006.01379.x.
   PubMed Web of Science ®Google Scholar
• Becker Buxton M, Vlahov D, Strathdee SA, Des Jarlais DC, Morse EV, Ouellet L, Kerndt P, Garfein RS. Association between injection practices and duration of injection among recently initiated injection drug users. Drug Alcohol Depend 2004;75:177–83. doi:10.1016/j.drugalcdep.2004.01.014.
   PubMed Web of Science ®Google Scholar
• Miller CL, Strathdee SA, Kerr T, Li K, Wood E. Factors associated with early adolescent initiation into injection drug use: implications for intervention programs. J Adolesc Health 2006;38:462–4. doi:10.1016/j.jadohealth.2005.03.004.
   PubMed Web of Science ®Google Scholar
• Kipke MD, Unger JB, Palmer RF, Edgington R. Drug use, needle sharing, and HIV risk among injection drug-using street youth. Subst Use Misuse. 1996;31:1167–87. doi:10.3109/10826089609063971.
   PubMed Web of Science ®Google Scholar
• Hahn JA, Page-Shafer K, Lum PJ, Ochoa K, Moss AR. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology (Baltimore, MD) 2001;34:180–7. doi:10.1053/jhep.2001.25759.
   PubMed Web of Science ®Google Scholar
• Nelson KE, Galai N, Safaeian M, Strathdee SA, Celentano DD, Vlahov D. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. Am J Epidemiol 2002;156:641–53. doi:10.1093/aje/kwf086.
   PubMed Web of Science ®Google Scholar
• Carneiro M, Fuller C, Doherty MC, Vlahov D. HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old. Drug Alcohol Depend1999;54:83–6. doi:10.1016/s0376-8716(98)00142-2.
   PubMed Web of Science ®Google Scholar
• Vlahov D, Fuller CM, Ompad DC, Galea S, Des Jarlais DC. Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health2004;81:14–9. doi:10.1093/jurban/jth083.
   PubMed Web of Science ®Google Scholar
• Fazel S, Bains P, Doll H. Substance abuse and dependence in prisoners: a systematic review. Addiction (Abingdon, England) 2006;101:181–91. doi:10.1111/j.1360-0443.2006.01316.x.
   PubMed Web of Science ®Google Scholar
• Koulierakis G, Gnardellis C, Agrafiotis D, Power KG. HIV risk behaviour correlates among injecting drug users in Greek prisons. Addiction (Abingdon, England). 2000;95:1207–16.
   PubMed Web of Science ®Google Scholar
• Malliori M, Sypsa V, Psichogiou M, Touloumi G, Skoutelis A, Tassopoulos N, Hatzakis A, Stefanis C. A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Addiction (Abingdon, England). 1998;93:243–51. doi:10.1046/j.1360-0443.1998.9322438.x.
   PubMed Web of Science ®Google Scholar
• Dolan K, Larney S. A review of HIV in prisons in Nepal. Kathmandu Univ Med J 1970;7:351–4. doi:10.3126/kumj.v7i4.2753.
   Google Scholar
• Dolan, K. A., et al. HIV education in a Siberian prison colony for drug-dependent males. Int J Equity Health 2004;3:7.
   Google Scholar
• Dolan, K. A., et al. Presence of hepatitis C virus in syringes confiscated in prisons in Australia. Journal of Gastroenterology and Hepatology 2009;24:1655–1657.
   Google Scholar